Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07140731 · ClinicalTrials.gov registry record · NA
The Symani Restore Study
A NA study of Moya Moya Disease, sponsored by Jacobs institute.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT07140731: Recruiting NA study of Moya Moya Disease, sponsored by Jacobs institute.
NCT07140731 is a NA study of Moya Moya Disease that is actively recruiting participants, run by Jacobs institute. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07140731, a NA study of Moya Moya Disease, is actively recruiting participants, sponsored by Jacobs institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
A research study for a neurosurgical procedure in adult patients with Moyamoya disease
Primary Outcome
Stable cerebral perfusion confirmed with CT Imaging
Conditions Studied
Interventions
- DEVICE Symani Surgical System
Study Locations (1)
New York
- Jacobs Institute - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-09-20 |
| Est. Completion | 2027-09-01 |
| Phase | NA |
What NCT07140731 shows while recruiting
NCT07140731 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Moya Moya Disease appearing as the primary indexed condition, and to 1 intervention - of which Symani Surgical System is the first listed.
NCT07140731 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07140731 about?
NCT07140731 is a clinical study titled "The Symani Restore Study". A research study for a neurosurgical procedure in adult patients with Moyamoya disease
What is the current status of trial NCT07140731?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-09-20. Estimated completion is 2027-09-01.
What conditions does trial NCT07140731 study?
This clinical trial studies the following conditions: Moya Moya Disease.
What interventions are being tested in trial NCT07140731?
The interventions under investigation include: Symani Surgical System (DEVICE).
Who is sponsoring clinical trial NCT07140731?
This trial is sponsored by Jacobs institute, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07140731 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Moya Moya Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07140731's enrollment target sits among peer trials
15 1882nd of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI